HIV vaccines. Viral envelope fails to deliver?
作者信息
Bolognesi D P, Matthews T J
出版信息
Nature. 1998 Feb 12;391(6668):638-9. doi: 10.1038/35504.
DOI:10.1038/35504
PMID:9490406
Abstract
摘要
相似文献
1
HIV vaccines. Viral envelope fails to deliver?艾滋病毒疫苗。病毒包膜未能发挥作用？
Nature. 1998 Feb 12;391(6668):638-9. doi: 10.1038/35504.
2
Public health. A sound rationale needed for phase III HIV-1 vaccine trials.公共卫生。HIV-1疫苗三期试验需要合理依据。
Science. 2004 Jan 16;303(5656):316. doi: 10.1126/science.1094620.
3
AIDS/HIV. Developing an AIDS vaccine: need, uncertainty, hope.艾滋病/艾滋病毒。开发艾滋病疫苗：需求、不确定性与希望。
Science. 2004 Jun 25;304(5679):1913-4. doi: 10.1126/science.1100368.
4
Virology. Moving forward in HIV vaccine development.病毒学。推进HIV疫苗研发。
Science. 2009 Nov 27;326(5957):1196-8. doi: 10.1126/science.1183278.
5
Update on HIV vaccines.HIV疫苗的最新情况。
STEP Perspect. 1997 Summer;9(2):5-6, 8-9.
6
Policy rebuttal. HIV vaccine trial justified.政策反驳。HIV疫苗试验合理。
Science. 2004 Feb 13;303(5660):961. doi: 10.1126/science.1096161.
7
Prime-boost immunization strategies against HIV.针对艾滋病病毒的初免-加强免疫策略。
AIDS Res Hum Retroviruses. 1998 Oct;14 Suppl 3:S299-309.
8
First AIDS vaccine trial launched.首次艾滋病疫苗试验启动。
Science. 1998 Jun 12;280(5370):1697.
9
AIDS research. Novel antibody response may explain HIV vaccine success.艾滋病研究。新型抗体反应或可解释HIV疫苗的成功。
Science. 2011 Sep 16;333(6049):1560. doi: 10.1126/science.333.6049.1560.
10
AIDS vaccines: back to 'plan A'.艾滋病疫苗：回归“第一方案”。
Nature. 2003 Jun 26;423(6943):912-4. doi: 10.1038/423912a.
引用本文的文献
1
A New Scientific Paradigm may be Needed to Finally Develop an HIV Vaccine.或许需要一种新的科学范式才能最终研发出艾滋病疫苗。
Front Immunol. 2015 Mar 18;6:124. doi: 10.3389/fimmu.2015.00124. eCollection 2015.
2
HIV type 1 Env precursor cleavage state affects recognition by both neutralizing and nonneutralizing gp41 antibodies.1型人类免疫缺陷病毒包膜前体的切割状态影响中和性和非中和性gp41抗体的识别。
AIDS Res Hum Retroviruses. 2011 Aug;27(8):877-87. doi: 10.1089/AID.2010.0281. Epub 2011 Jan 19.
3
The V1/V2 domain of gp120 is a global regulator of the sensitivity of primary human immunodeficiency virus type 1 isolates to neutralization by antibodies commonly induced upon infection.gp120的V1/V2结构域是原发性人类免疫缺陷病毒1型分离株对感染后通常诱导产生的抗体中和敏感性的全局调节因子。
J Virol. 2004 May;78(10):5205-15. doi: 10.1128/jvi.78.10.5205-5215.2004.
4
Modifications of the human immunodeficiency virus envelope glycoprotein enhance immunogenicity for genetic immunization.人免疫缺陷病毒包膜糖蛋白的修饰增强了基因免疫的免疫原性。
J Virol. 2002 Jun;76(11):5357-68. doi: 10.1128/jvi.76.11.5357-5368.2002.
5
Comparison of the antibody repertoire generated in healthy volunteers following immunization with a monomeric recombinant gp120 construct derived from a CCR5/CXCR4-using human immunodeficiency virus type 1 isolate with sera from naturally infected individuals.用源自一株使用CCR5/CXCR4的1型人类免疫缺陷病毒分离株的单体重组gp120构建体免疫健康志愿者后产生的抗体库与自然感染个体的血清进行比较。
J Virol. 1999 Feb;73(2):1740-5. doi: 10.1128/JVI.73.2.1740-1745.1999.
Zotero 插件